SCHEMBL8046900

SCHEMBL8046900

CC(CO)C(CO)OS(=O)(=O)OS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL720023 0.73
SCHEMBL8046896 0.69 TDP1 (0.32)
SCHEMBL27612654 0.68 CA1 (0.30)
SCHEMBL9651406 0.68 TSHR (0.36)
Propylene Glycol SCHEMBL28667172 0.68 TDP1 (0.53)
SCHEMBL8506222 0.68 TP53 (0.32)
SCHEMBL17115793 0.67 TDP1 (0.33)
Glycerin SCHEMBL8504732 0.66 LMNA (0.45)
SCHEMBL15847885 0.64 ALDH1A1 (0.41)
SCHEMBL10729251 0.63 CA2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999045947-A9 IN VITRO FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES UNIV WASHINGTON (US) 2000-03-02 WO claimed